GLP-1 Treatment Late in Life Extends Lifespan in Animal Model

Data ReadoutpositivesemaglutidePositive

AI Analysis

Summary

An NIH-funded study found that semaglutide extended lifespan in older, healthy mice by mitigating aging-related deterioration. This preclinical finding suggests potential longevity benefits of GLP-1 treatment later in life.

Outcome Details

GLP-1 drug semaglutide extended lifespan in older, healthy mice by tempering detrimental effects of aging

Importance:3/10

Sentiment:

0.60

GLP-1semaglutideaginglifespan extensionanimal modelNIH-funded

Related Companies

$NHPAP

Read the original article

Published by Drugs.com Clinical Trial Results on September 2, 2026 10:09 PM

Read Original